SG/PUT/AMGEN/220/0.1/20.09.24 | Delayed Deutsche Boerse AG 03:49:02 2024-07-03 EDT | ||
| 0.022 EUR | -21.43% |
|
| Current month | +27.27% | ||
| 1 month | -51.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 0.022 | -21.43% |
| 24-07-02 | 0.028 | -3.45% |
| 24-07-01 | 0.029 | +31.82% |
| 24-06-28 | 0.022 | +4.76% |
| 24-06-27 | 0.021 | +40.00% |
Delayed Quote Deutsche Boerse AG
Last update July 03, 2024 at 03:49 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SV6QSU |
| ISIN | DE000SV6QSU5 |
| Date issued | 2023-05-24 |
| Strike | 220 $ |
| Maturity | 2024-09-20 (80 Days) |
| Parity | 10 : 1 |
| Emission price | 2.03 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.4 € |
|---|---|
| Lowest since issue | 0.001 € |
| Delta | -0.02x |
| Omega | 14.54 |
| Premium | 29.33x |
| Gearing | 750.25x |
| Moneyness | 0.7081 |
| Difference Strike | -90.7 $ |
| Difference Strike % | -41.23% |
| Spread | 0.033 € |
| Spread % | 60.00% |
| Intrinsic value | 0.000000 |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.82%
- Stock Market
- Warrants
- Warrant
